Publication | Open Access

Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma

Prognostic BiomarkersOncologyPancreatic CancerGastrointestinal OncologyMedicineGemcitabine-based TherapyPathologyCancer GenomicsPancreatic Ductal AdenocarcinomaMolecular DiagnosticsCell BiologyCancer ResearchTumor BiologyLaminin γ2